Memorial Sloan-Kettering Cancer Center (MSKCC) and IBM have agreed to collaborate on the development of a tool built upon IBM Watson in order to provide medical professionals with improved access to current and comprehensive cancer data and practices. The resulting decision support tool will help doctors everywhere create individualized cancer diagnostic and treatment recommendations for their patients based on current evidence. The initiative will combine the computational power of ...

REGISTER NOW TO ACCESS THIS ARTICLE

All registered users get access to premium content on POWER IT Pro for free.

Already registered? Log in here.